BMY
Bristol-Myers Squibb Company
NYSE · Healthcare · Drug Manufacturers - General · US
$66.82
−1.87%Forward multiples
Based on analyst estimates
- P/E forward
- 10.42x
- P/E 2026E
- 9.64x
- P/E 2027E
- 10.19x
- P/E 2028E
- 11.86x
- P/S forward
- 2.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.72x
- PEG TTM
- 0.36x
- Price / book
- 6.12x
- Price / sales
- 2.78x
- Price / cash flow
- 10.68x
Enterprise value
- Enterprise value
- $168.5B
- EV / sales
- 3.43x
- EV / EBITDA
- 10.11x
- EV / EBIT
- 12.12x
- Market cap
- $136.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026